NEVIRAPINE (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the NEVIRAPINE drug offered from Aurobindo Pharma Limited. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
| NON-PROPRIETARY NAME: | NEVIRAPINE |
| SUBSTANCE NAME: | NEVIRAPINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-11-23 |
| END MARKETING DATE: | 0000-00-00 |
NEVIRAPINE HUMAN PRESCRIPTION DRUG Details:
| Item Description | NEVIRAPINE from Aurobindo Pharma Limited |
| LABELER NAME: | Aurobindo Pharma Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2016-11-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65862-932_db5fd05d-7eb9-4291-8f74-a9c428afe2f4 |
| PRODUCT NDC: | 65862-932 |
| APPLICATION NUMBER: | ANDA208616 |
Other NEVIRAPINE Pharmaceutical Manufacturers / Labelers:
